olaparib
astrazeneca
['solo1', 'olaparib']
#esmo22 7-yr solo1. median os not reached with olaparib vs 75.2 mo with pbo hr = 0.55; p = .0004 (&lt;.0001 required for predefined significance). 44% of pts on pbo arm received subsequent parpi tx 
CME experts Sara Fagerlie, PhD, CHCP & Mindy Tanzola, PhD have joined forces at Front Row to help clinicians & educators manage the oncology information deluge